HPCM invests $150m in medical diagnostics company Patho Care
With this funding, Patho Care aims to expand its service range in the diagnostics testing sector.
Drug Development
UBC researchers develop new coating for medical devices
Thermo Fisher’s Oncomine gains FDA approval as brain tumor diagnostic
Clearside’s wet AMD drug-device combo shines in Phase IIb study
Starton successfully delivers cancer drug using on-body injector
Crossject secures funding from French Government for needle-free platform
NVIDIA doubles down on AI in healthcare with drug discovery deals
FDA doubles down on patient engagement to support rare disease research
